Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Merck
Moodys
US Department of Justice
Fuji
Baxter
McKinsey
Farmers Insurance
Teva
AstraZeneca

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078212

« Back to Dashboard
NDA 078212 describes BENAZEPRIL HYDROCHLORIDE, which is a drug marketed by Sandoz, Teva, Aurobindo Pharma, Prinston Inc, Amneal Pharms, Apotex Inc, Mylan, Ivax Sub Teva Pharms, Sun Pharm Inds Ltd, Zydus Pharms Usa, Actavis Labs Fl Inc, Genpharm, and Mylan Pharms Inc, and is included in nineteen NDAs. It is available from forty suppliers. Additional details are available on the BENAZEPRIL HYDROCHLORIDE profile page.

The generic ingredient in BENAZEPRIL HYDROCHLORIDE is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.

Summary for NDA: 078212

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078212

Suppliers and Packaging for NDA: 078212

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENAZEPRIL HYDROCHLORIDE
benazepril hydrochloride
TABLET;ORAL 078212 ANDA PD-Rx Pharmaceuticals, Inc. 43063-748 43063-748-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-748-30)
BENAZEPRIL HYDROCHLORIDE
benazepril hydrochloride
TABLET;ORAL 078212 ANDA Aurobindo Pharma Limited 65862-116 65862-116-01 100 TABLET, FILM COATED in 1 BOTTLE (65862-116-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:May 22, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:May 22, 2008TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:May 22, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Cipla
Deloitte
McKesson
US Army
McKinsey
US Department of Justice
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot